Patent Yard Sign in
Canadian application, no grantCanada

Lipid metabolism transcription factor

CA 2374376 A1 · Owner: Baughn, Mariah R. · Inventors: Baughn, Mariah R.; Kaser, Matthew R.; Yue, Henry

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention provides a mammalian nucleic acid sequence and fragments thereof. It also provides for the use of these nucleic acid sequences in a model system for the characterization, diagnosis evaluation, treatment, or , prevention of conditions diseases and disorders associated with expression of the mammalian nucleic acid sequence. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid sequence.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 15, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 15, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 15, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 15, 2000
GrantedNo grant recorded
Term endedMay 15, 2020
Patent numberCA 2374376 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedMay 15, 2000Term endedMay 15, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.